Cargando…

Circulating Hepatitis B Surface Antigen Particles Carry Hepatocellular microRNAs

Hepatitis B virus (HBV) produces high quantities of subviral surface antigen particles (HBsAg) which circulate in the blood outnumbering virions of about 1\10(3–6) times. In individuals coinfected with the defective hepatitis Delta virus (HDV) the small HDV-RNA-genome and Delta antigen circulate as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Novellino, Luisa, Rossi, Riccardo L., Bonino, Ferruccio, Cavallone, Daniela, Abrignani, Sergio, Pagani, Massimiliano, Brunetto, Maurizia R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314627/ https://www.ncbi.nlm.nih.gov/pubmed/22470417 http://dx.doi.org/10.1371/journal.pone.0031952

Ejemplares similares

HBeAg-Negative/Anti-HBe-Positive Chronic Hepatitis B: A 40-Year-Old History
por: Bonino, Ferruccio, et al.
Publicado: (2022)

The Circulating miRNA Profile of Chronic Hepatitis D and B Patients Is Comparable but Differs from That of Individuals with HBeAg-Negative HBV Infection
por: Cavallone, Daniela, et al.
Publicado: (2023)

A Serum MicroRNA Signature Is Associated with the Immune Control of Chronic Hepatitis B Virus Infection
por: Brunetto, Maurizia Rossana, et al.
Publicado: (2014)

Management and Treatment of Patients with Chronic Hepatitis B: Towards Personalized Medicine
por: Colombatto, Piero, et al.
Publicado: (2022)

Modeling Hepatocellular Carcinoma Cells Dynamics by Serological and Imaging Biomarkers to Explain the Different Responses to Sorafenib and Regorafenib
por: Colombatto, Piero, et al.
Publicado: (2021)

Serum microRNAs as Biomarkers of Human Lymphocyte Activation in Health and Disease
por: de Candia, Paola, et al.
Publicado: (2014)

Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease
por: Yuan, Quan, et al.
Publicado: (2015)

Hepatitis B surface antigen levels: association with 5-year response to peginterferon alfa-2a in hepatitis B e-antigen-negative patients
por: Marcellin, Patrick, et al.
Publicado: (2012)

Brain-gut-liver interactions across the spectrum of insulin resistance in metabolic fatty liver disease
por: Rebelos, Eleni, et al.
Publicado: (2021)

Effects of Different Scan Projections on the Quantitative Ultrasound-Based Evaluation of Hepatic Steatosis
por: De Rosa, Laura, et al.
Publicado: (2022)

Thermal Care of Functional Dyspepsia Based on Bicarbonate-Sulphate-Calcium Water: A Sequential Clinical Trial
por: Rocca, Giuseppe, et al.
Publicado: (2007)

T cell receptor-therapy in HBV-related hepatocellularcarcinoma
por: Bertoletti, Antonio, et al.
Publicado: (2015)

Different Kinetics of HBV-DNA and HBsAg in HCV Coinfected Patients during DAAs Therapy
por: Colombatto, Piero, et al.
Publicado: (2022)

Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein
por: Crotta, Stefania, et al.
Publicado: (2002)

Long Intergenic Non-Coding RNAs: Novel Drivers of Human Lymphocyte Differentiation
por: Panzeri, Ilaria, et al.
Publicado: (2015)

Circulating microRNAs in aging
por: Bonafè, Massimiliano, et al.
Publicado: (2015)

Evidence of a Gastro-Duodenal Effect on Adipose Tissue and Brain Metabolism, Potentially Mediated by Gut–Liver Inflammation: A Study with Positron Emission Tomography and Oral (18)FDG in Mice
por: Guzzardi, Maria Angela, et al.
Publicado: (2022)

Normalization of circulating microRNA expression data obtained by quantitative real-time RT-PCR
por: Marabita, Francesco, et al.
Publicado: (2016)

Hepatitis B Virus RNA Detection and a Mindful Use of Serum Hepatitis B Virus DNA and Hepatitis B Surface Antigen Measures in Clinical Practice
por: Brunetto, Maurizia R.
Publicado: (2020)

Surveillance for hepatocellular carcinoma in chronic viral hepatitis: Is it time to personalize it?
por: Demirtas, Coskun Ozer, et al.
Publicado: (2021)

Maternal High-Fat Feeding Affects the Liver and Thymus Metabolic Axis in the Offspring and Some Effects Are Attenuated by Maternal Diet Normalization in a Minipig Model
por: La Rosa, Federica, et al.
Publicado: (2021)

Circulating microRNAs and Their Role in Multiple Myeloma
por: Federico, Cinzia, et al.
Publicado: (2019)

Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
por: Jin, Yu, et al.
Publicado: (2019)

Circulating myocardial microRNAs from infarcted hearts are carried in exosomes and mobilise bone marrow progenitor cells
por: Cheng, Min, et al.
Publicado: (2019)

miRiadne: a web tool for consistent integration of miRNA nomenclature
por: Bonnal, Raoul J. P., et al.
Publicado: (2015)

Predictive Power of Tissue and Circulating Biomarkers for the Severity of Biopsy-Validated Chronic Liver Diseases
por: Bocci, Guido, et al.
Publicado: (2022)

Maturation of the Visceral (Gut-Adipose-Liver) Network in Response to the Weaning Reaction versus Adult Age and Impact of Maternal High-Fat Diet
por: Guzzardi, Maria Angela, et al.
Publicado: (2021)

The Double Face of Exosome-Carried MicroRNAs in Cancer Immunomodulation
por: Alfonsi, Romina, et al.
Publicado: (2018)

Circulating microRNAs in Medicine
por: Pozniak, Tetiana, et al.
Publicado: (2022)

Serum-Circulating microRNAs in Sporadic Inclusion Body Myositis
por: Lucchini, Matteo, et al.
Publicado: (2023)

Circulating MicroRNAs Are Not Eliminated by Hemodialysis
por: Martino, Filippo, et al.
Publicado: (2012)

Circulating MicroRNAs as Biomarkers for Sepsis
por: Benz, Fabian, et al.
Publicado: (2016)

Circulating microRNAs in Fabry Disease
por: Xiao, Ke, et al.
Publicado: (2019)

Circulating MicroRNAs in Gastrointestinal Cancer
por: Ohtsuka, Masahisa, et al.
Publicado: (2021)

Stability of circulating microRNAs in serum
por: Kupec, Tomas, et al.
Publicado: (2022)

Circulating microRNAs in Hidradenitis Suppurativa
por: De Felice, Bruna, et al.
Publicado: (2022)

Diagnostic and Predictive Values of Circulating Extracellular Vesicle-Carried microRNAs in Ischemic Heart Disease Patients With Type 2 Diabetes Mellitus
por: Zhang, Li, et al.
Publicado: (2022)

Circulating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma
por: Afonso, Marta B., et al.
Publicado: (2016)

Circulating MicroRNAs as Biomarkers in Hepatocellular Carcinoma Screening: A Validation Set From China
por: Jiang, Li, et al.
Publicado: (2015)

Comprehensive analysis of circulating microRNAs as predictive biomarkers for sorafenib therapy outcome in hepatocellular carcinoma
por: Kohno, Tomoki, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kabqg3blolurs0a23psq1uqfuj